Quadrant Capital Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-139
| Closed | -$18.3K | – | 2741 |
|
|
2025
Q1 | $18.3K | Buy |
139
+90
| +184% | +$11.9K | ﹤0.01% | 2061 |
|
|
2024
Q4 | $4.09K | Hold |
49
| – | – | ﹤0.01% | 2351 |
|
|
2024
Q3 | $3.59K | Hold |
49
| – | – | ﹤0.01% | 2387 |
|
|
2024
Q2 | $3.36K | Buy |
49
+4
| +9% | +$274 | ﹤0.01% | 2383 |
|
|
2024
Q1 | $3.11K | Hold |
45
| – | – | ﹤0.01% | 2416 |
|
|
2023
Q4 | $3.22K | Buy |
45
+33
| +275% | +$2.36K | ﹤0.01% | 2375 |
|
|
2023
Q3 | $626 | Sell |
12
-4
| -25% | -$209 | ﹤0.01% | 2539 |
|
|
2023
Q2 | $1.01K | Hold |
16
| – | – | ﹤0.01% | 2497 |
|
|
2023
Q1 | $867 | Buy |
16
+7
| +78% | +$379 | ﹤0.01% | 2554 |
|
|
2022
Q4 | $476 | Sell |
9
-73
| -89% | -$3.86K | ﹤0.01% | 2628 |
|
|
2022
Q3 | $4K | Sell |
82
-30
| -27% | -$1.46K | ﹤0.01% | 2244 |
|
|
2022
Q2 | $6K | Buy |
112
+103
| +1,144% | +$5.52K | ﹤0.01% | 1924 |
|
|
2022
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 2428 |
|
|
2021
Q4 | $0 | Buy |
9
+5
| +125% | – | ﹤0.01% | 2729 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 2687 |
|
|
2021
Q2 | $0 | Sell |
4
-15
| -79% | – | ﹤0.01% | 2603 |
|
|
2021
Q1 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 2325 |
|
|
2020
Q4 | – | Sell |
-8
| Closed | – | – | 2393 |
|
|
2020
Q3 | $0 | Sell |
8
-13
| -62% | – | ﹤0.01% | 2338 |
|
|
2020
Q2 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 2167 |
|